• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

色素性 PRRX1::NCOA1 重排纤维母细胞瘤:一种新兴间叶性肿瘤的罕见形态学变异型。

Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor.

机构信息

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

出版信息

J Cutan Pathol. 2022 Sep;49(9):802-807. doi: 10.1111/cup.14262. Epub 2022 Jun 10.

DOI:10.1111/cup.14262
PMID:35583270
Abstract

PRRX

:NCOAx-rearranged fibroblastic tumor is a recently described, morphologically distinctive subcutaneous fibroblastic tumor with benign behavior. To date, 12 cases have been reported. Here, we report a new case of PRRX::NCOAx-rearranged fibroblastic tumor showing a prominent pigmented component. The lesion occurred on the shoulder of a 23-year-old male. It was an at least 2.5 cm subcutaneous tumor with a multinodular and plexiform appearance. Morphologically, the tumor was characterized by a variably cellular proliferation of uniform oval to spindle cells arranged in fascicles and cords within a myxocollagenous stroma. Irregular, elongated, dilated vessels were prominent at the periphery of tumor nodules. In addition, nests and clusters of pigment-laden epithelioid and dendritic cells were present. Immunohistochemically, the non-pigmented tumor cells showed patchy positivity for factor XIIIa and focal positivity for S100 protein. The pigmented cells were positive for S100 protein, SOX10, MITF, and a pan-melanocytic cocktail (Melan-A, HMB-45, and tyrosinase). Next-generation RNA sequencing identified an in-frame PRRX1::NCOA1 fusion. In summary, this case highlights a rare pigmented variant of PRRX::NCOAx-rearranged fibroblastic tumor, expanding the morphologic spectrum of this newly described mesenchymal tumor.

摘要

PRRX

:NCOAx 重排型纤维母细胞性肿瘤是一种新近描述的具有独特形态学特征的皮下纤维母细胞性肿瘤,具有良性行为。迄今为止,已有 12 例报道。在此,我们报告 1 例新的 PRRX::NCOAx 重排型纤维母细胞性肿瘤,其表现出显著的色素成分。病变发生于 23 岁男性的肩部。这是一个至少 2.5 厘米的皮下肿瘤,具有多结节和丛状外观。形态上,肿瘤的特征是在黏液样胶原基质中排列成束状和条索状的均匀椭圆形至梭形细胞呈不同程度的细胞增生。不规则、伸长的扩张血管在肿瘤结节的外围很突出。此外,还存在色素沉着的上皮样和树突状细胞巢和簇。免疫组化染色显示,非色素性肿瘤细胞呈斑驳阳性表达 for factor XIIIa,局灶性阳性表达 S100 蛋白。色素性细胞阳性表达 S100 蛋白、SOX10、MITF 和泛黑色素细胞鸡尾酒(Melan-A、HMB-45 和酪氨酸酶)。下一代 RNA 测序鉴定出一个框架内的 PRRX1::NCOA1 融合。总之,本病例突出了 PRRX::NCOAx 重排型纤维母细胞性肿瘤的一种罕见的色素变体,扩展了这种新描述的间叶性肿瘤的形态学谱。

相似文献

1
Pigmented PRRX1::NCOA1-rearranged fibroblastic tumor: A rare morphologic variant of an emerging mesenchymal tumor.色素性 PRRX1::NCOA1 重排纤维母细胞瘤:一种新兴间叶性肿瘤的罕见形态学变异型。
J Cutan Pathol. 2022 Sep;49(9):802-807. doi: 10.1111/cup.14262. Epub 2022 Jun 10.
2
PRRX1-NCOA1-rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under-recognised, distinctive mesenchymal tumour.PRRX1-NCOA1重排的成纤维细胞性肿瘤:对6例可能未被充分认识的独特间叶性肿瘤的临床病理、免疫组化及分子遗传学研究
Histopathology. 2021 Dec;79(6):997-1003. doi: 10.1111/his.14454. Epub 2021 Sep 3.
3
PRRX-NCOA1/2 rearrangement characterizes a distinctive fibroblastic neoplasm.PRRX-NCOA1/2 重排特征性地表现为一种独特的成纤维细胞肿瘤。
Genes Chromosomes Cancer. 2019 Oct;58(10):705-712. doi: 10.1002/gcc.22762. Epub 2019 Apr 30.
4
PRRX1-fused mesenchymal neoplasm: A novel PRRX1::NCOA1 fusion transcript.PRRX1 融合性间叶性肿瘤:一种新型的 PRRX1::NCOA1 融合转录本。
J Cutan Pathol. 2024 Nov;51(11):828-833. doi: 10.1111/cup.14683. Epub 2024 Jul 10.
5
"PRRX1-rearranged mesenchymal tumors": expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature.“PRRX1 重排间叶性肿瘤”:通过重新命名,扩大了最近描述的实体的免疫组织化学特征和分子谱。
Virchows Arch. 2023 Aug;483(2):207-214. doi: 10.1007/s00428-023-03575-w. Epub 2023 Jun 20.
6
The emerging PRRX1-NCOA fibroblastic neoplasm: a combined reappraisal of published tumors and two new cases.新兴的 PRRX1-NCOA 成纤维细胞性肿瘤:对已发表肿瘤和两例新病例的综合再评估。
Virchows Arch. 2022 Jul;481(1):111-116. doi: 10.1007/s00428-021-03219-x. Epub 2021 Oct 14.
7
Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.具有局灶性横纹肌母细胞分化的双表型鼻窦肉瘤中的新型PAX3-NCOA1融合基因
Am J Surg Pathol. 2016 Jan;40(1):51-9. doi: 10.1097/PAS.0000000000000492.
8
Clinicopathologic Characterization of GREB1-rearranged Uterine Sarcomas With Variable Sex-Cord Differentiation.具有可变性索分化的 GREB1 重排型子宫肉瘤的临床病理特征。
Am J Surg Pathol. 2019 Jul;43(7):928-942. doi: 10.1097/PAS.0000000000001265.
9
MED15::ATF1-Rearranged Tumor: A Novel Cutaneous Tumor With Melanocytic Differentiation.MED15::ATF1 重排肿瘤:一种具有黑色素细胞分化特征的新型皮肤肿瘤。
Mod Pathol. 2024 Apr;37(4):100438. doi: 10.1016/j.modpat.2024.100438. Epub 2024 Jan 24.
10
EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.EWSR1-SMAD3 重排的纤维母细胞性肿瘤:在日益复杂的纤维母细胞/肌纤维母细胞性肿瘤群中出现的一种新实体。
Am J Surg Pathol. 2018 Oct;42(10):1325-1333. doi: 10.1097/PAS.0000000000001109.

引用本文的文献

1
"PRRX1-rearranged mesenchymal tumors": expanding the immunohistochemical profile and molecular spectrum of a recently described entity with the proposed revision of nomenclature.“PRRX1 重排间叶性肿瘤”:通过重新命名,扩大了最近描述的实体的免疫组织化学特征和分子谱。
Virchows Arch. 2023 Aug;483(2):207-214. doi: 10.1007/s00428-023-03575-w. Epub 2023 Jun 20.